Filing Details

Accession Number:
0001144204-11-045470
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-11 07:39:39
Reporting Period:
2011-08-10
Filing Date:
2011-08-11
Accepted Time:
2011-08-11 07:39:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1114220 Keryx Biopharmaceuticals Inc KERX Pharmaceutical Preparations (2834) 134087132
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1381064 Jr Wyche Fowler C/O Keryx Biopharmaceuticals, Inc.
750 Lexington Avenue
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-10 5,000 $3.07 125,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reflects the weighted average purchase price. The range of prices for such transactions is $3.0682 to $3.0700. The reporting person effected multiple same-way open market purchases on the same day at different prices through a trade order executed by a broker dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission Staff, the issuer or a stakeholder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. Of the 125,000 shares, 25,000 shares are restricted common stock.